This inventor holds 1 USPTO granted patent. Top assignee: Jinan University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Junping Pan in Neurodegenerative Disease Treatment
Introduction
Junping Pan is an accomplished inventor based in Guangzhou, China. He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. His innovative work focuses on the use of natural compounds to promote cellular health and mitigate the effects of debilitating conditions.
Latest Patents
Junping Pan holds a patent for the "Use of Crassifolin A in preparation of drug for promoting mitophagy and treating neurodegenerative diseases." This invention discloses the potential of Crassifolin A, a diterpene compound, to significantly enhance mitophagy levels. The compound promotes the removal of damaged mitochondria, thereby maintaining cellular homeostasis. Furthermore, Crassifolin A can easily penetrate the blood-brain barrier, making it a promising candidate for treating neurodegenerative diseases. The compound is derived from a Thickleaf croton root, which offers abundant medicinal sources, low toxicity, and minimal side effects.
Career Highlights
Junping Pan is affiliated with Jinan University, where he conducts research and develops innovative solutions for health-related challenges. His work has garnered attention for its potential impact on the treatment of neurodegenerative diseases, showcasing his commitment to advancing medical science.
Collaborations
He collaborates with notable colleagues, including Yubo Zhang and Fei Xiao, to further enhance the research and development of therapeutic applications based on his findings.
Conclusion
Junping Pan's innovative approach to utilizing Crassifolin A represents a significant advancement in the treatment of neurodegenerative diseases. His contributions to the field highlight the importance of natural compounds in modern medicine and offer hope for improved therapeutic options.